Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-18

Clinical Trial Update: A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update for PHP-201 evaluating efficacy and safety in primary open angle glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHP-201

Snippet

Sponsor: pH Pharma | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: UNKNOWN